Results 141 to 150 of about 63,671 (294)

Pancreatic Enzyme Replacement Therapy Improves Exclusive Enteral Nutrition Related Diarrhea in Crohn's Disease: A Prospective Randomized Trial

open access: yesUnited European Gastroenterology Journal, EarlyView.
ABSTRACT Background & Aims Previous results showed that combined treatment of biologics and exclusive enteral nutrition (EEN) brought moderate‐to‐severe Crohn's disease patients significant improvements in clinical and endoscopic outcomes. Despite its essential role and favorable safety profile, EEN in the treatment of adult Crohn's disease is ...
Jian Kang   +12 more
wiley   +1 more source

IMMUNOSUPPRESSION WITH AZATHIOPRINE, PREDNISONE, AND CYCLOPHOSPHAMIDE1

open access: bronze, 1979
John Jeffery   +3 more
openalex   +1 more source

Hypersensitivity to azathioprine

open access: yesJournal of Dermatological Treatment, 1991
S. Veraldi, R. Caputo
openaire   +2 more sources

Pediatric Autoimmune Pancreatitis: Clinical Findings and Outcomes in Sweden

open access: yesUnited European Gastroenterology Journal, EarlyView.
ABSTRACT Introduction Pediatric autoimmune pancreatitis (AIP) is a rare form of pancreatitis in children with poorly understood pathophysiology. It is a recognized risk factor for chronic pancreatitis in approximately 4% of pediatric cases. This study aims to describe the demographics, clinical characteristics, and outcomes of a large Swedish cohort of
Miroslav Vujasinovic   +9 more
wiley   +1 more source

THE EFFECT OF AZATHIOPRINE ON LUPUS GLOMERULONEPHRITIS

open access: bronze, 1972
John P. Hayslett   +3 more
openalex   +1 more source

Differences in the Fecal Metabolome of Autoimmune Pancreatitis Patients

open access: yesUnited European Gastroenterology Journal, EarlyView.
ABSTRACT Background Chronic pancreatitis is a risk factor for pancreatic cancer. Autoimmune pancreatitis is a unique form of chronic pancreatitis that is primarily characterized by its immune mediate etiology, clinically resembling pancreatic cancer, yet uniquely responsive to steroid treatment.
Vladyslav Dovhalyuk   +5 more
wiley   +1 more source

Response to COVID‐19 vaccine is reduced in patients with inflammatory bowel disease, but improved with additional dose

open access: yesJournal of Gastroenterology and Hepatology, Volume 38, Issue 1, Page 44-51, January 2023., 2023
Abstract Background Coronavirus disease 2019 (COVID‐19) vaccination is recommended for patients with inflammatory bowel disease (IBD); however, suppressed immune responses have been reported for fully vaccinated patients under immunosuppressive therapy, mainly from Western countries.
Hisashi Shiga   +13 more
wiley   +1 more source

Treatment of Neurogenic Voice Disorders

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT This overview serves as a foundational resource for clinicians caring for neurologically complex patients presenting with voice complaints. Neurogenic voice disorders are diverse in their clinical presentations and therapeutic approaches. A thorough medical history, including family history, detailed laryngeal examination, voice assessments ...
Mausumi Syamal
wiley   +1 more source

Home - About - Disclaimer - Privacy